NCT06165848 is a clinical trial in Burn Unspecified Degree, sponsored by T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi.

Who is sponsoring NCT06165848?

NCT06165848 is sponsored by T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi.

What condition does NCT06165848 study?

NCT06165848 studies Burn Unspecified Degree, Deep Sedation.

Is NCT06165848 still recruiting?

NCT06165848 is currently completed. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT06165848

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects Of Different Anesthesia Applications On Mood, Depression, And Anxiety Levels In Burn Patients

Completed Last updated 12 December 2023

What this trial tests

trial in Burn Unspecified Degree in 67 participants. Completed in 7 June 2021.

Timeline

9 July 2020

Primary endpoint
10 August 2020

7 June 2021

Quick facts

Lead sponsor	T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi
Status	Completed
Study type	OBSERVATIONAL
Enrollment	67
Start date	9 July 2020
Primary completion	10 August 2020
Estimated completion	7 June 2021
Sites	1 location across Turkey (Türkiye)

Conditions studied

Burn Unspecified Degree — all drugs for Burn Unspecified Degree →
Deep Sedation — all drugs for Deep Sedation →

Sponsor

T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi

Who can join

Adults 18 to 65, any sex, with Burn Unspecified Degree or Deep Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06165848 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06165848.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing